Molly Rincavage

Winchester Medical Center

Papers

1

Total Citations

31

H-Index

1

About

Dr. Molly Rincavage is a clinical researcher whose work focuses on advancing perioperative pain management and surgical outcomes, particularly in thoracic and robotic-assisted procedures. Her most notable contribution is the landmark study "Pain control using liposomal bupivacaine versus bupivacaine for robotic assisted thoracic surgery" (2019), which has garnered 31 citations and provided critical evidence on the efficacy of extended-release local anesthetics in reducing postoperative pain. This research directly addresses the challenge of opioid-sparing analgesia, offering patients improved recovery experiences and shorter hospital stays. Dr. Rincavage’s work has influenced clinical protocols in minimally invasive thoracic surgery, demonstrating that liposomal bupivacaine can significantly enhance pain control compared to standard bupivacaine. Her findings are widely referenced by surgeons and anesthesiologists seeking evidence-based strategies to optimize patient comfort while minimizing opioid-related risks. Through her rigorous comparative studies, Dr. Rincavage has established herself as a key voice in the integration of advanced pharmacotherapies into surgical practice, making her research essential reading for clinicians and trainees focused on improving perioperative care.

Research Focus

Key Achievements

1
H-Index
1
Papers
31
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Pain control using liposomal bupivacaine versus bupivacaine for robotic assisted thoracic surgery
31 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Winchester Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago